These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6241828)

  • 1. Enhancement of cytostatic activity of macrophages against MOPC-315 tumour cells by combined cyclophosphamide administration and immunisation with glutaraldehyde-treated tumour cells.
    Ophir R; Ben-Efraim S; Relyveld EH
    Asian Pac J Allergy Immunol; 1984 Dec; 2(2):175-80. PubMed ID: 6241828
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction by cyclophosphamide administration of two distinct anti-tumor effector cells at tumor site and spleen of mice transplanted with MOPC-104E plasmacytoma.
    Nio Y; Ohgaki K; Tobe T
    J Clin Lab Immunol; 1989 May; 29(1):37-43. PubMed ID: 2534133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cyclophosphamide administration on immunoprophylaxis and immunotherapy with glutaraldehyde-treated MOPC-315 syngeneic tumour cells.
    Ophir R; Relyveld EH; Ben-Efraim S
    Asian Pac J Allergy Immunol; 1984 Jun; 2(1):37-42. PubMed ID: 6442157
    [No Abstract]   [Full Text] [Related]  

  • 4. Importance of timing in cyclophosphamide therapy of MOPC-315 tumor-bearing mice.
    Hengst JC; Mokyr MB; Dray S
    Cancer Res; 1980 Jul; 40(7):2135-41. PubMed ID: 6446379
    [No Abstract]   [Full Text] [Related]  

  • 5. Stimulation in the primary and secondary mixed lymphocyte reaction by mitogen-stimulated, glutaraldehyde-fixed mouse spleen cells.
    Lightbody J; Kong YM
    Transplant Proc; 1977 Mar; 9(1):679-81. PubMed ID: 141137
    [No Abstract]   [Full Text] [Related]  

  • 6. Mitogen-stimulated glutaraldehyde-fixed spleen cells: ability to stimulate in the mixed lymphocyte reaction and generate effector cells in cell-mediated lympholysis.
    Lightbody JJ; Kong YM
    J Immunol; 1976 Oct; 117(4):1336-9. PubMed ID: 135809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour immunoprophylaxis in mice using glutaraldehyde-treated syngeneic myeloma cells.
    Ben-Efraim S; Ophir R; Relyveld EH
    Br J Cancer; 1981 Apr; 43(4):554-7. PubMed ID: 6786316
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of resistance to ascites tumor in mice with MFS-180 cells treated with glutaraldehyde, lipopolysaccharide, and concanavalin A.
    Nerkar DP; Chander R; Bandekar JR; Lewis NF
    Cancer Res; 1981 Jul; 41(7):2922-4. PubMed ID: 6788363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced susceptibility of glutaraldehyde-treated tumor cells to antibody-dependent macrophage-mediated cytolysis.
    Iwata-Dohi N; Esumi-Kurisu M; Ikenami M; Sadatsune K; Mizuno D; Yamazaki M
    Cancer Res; 1982 Aug; 42(8):3196-200. PubMed ID: 6807539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some characteristics of the cyclophosphamide-induced immunopotentiating cells in the spleen of mice bearing a large MOPC-315 tumor.
    Mokyr MB; Ye QW
    Cancer Res; 1985 Oct; 45(10):4932-9. PubMed ID: 4027979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of BCG and cyclophosphamide on the antitumor activity of mouse peritoneal macrophages].
    Gromov SA; Okulov VB; Voĭtenkov BO
    Eksp Onkol; 1989; 11(3):63-6. PubMed ID: 2752946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The induction of tumour immunity in mice using glutaraldehyde-treated tumor cells.
    Sanderson CJ; Frost P
    Nature; 1974 Apr; 248(5450):690-1. PubMed ID: 4208483
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune response to glutaraldehyde-treated cells. I. Dissociation of immunological memory and antibody production.
    Ramos A; Zavala F; Hoecker G
    Immunology; 1979 Apr; 36(4):775-80. PubMed ID: 108207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the synthetic capacity and antigenic expression of glutaraldehyde-fixed target cells.
    Bubbers JE; Henney CS
    J Immunol; 1975 Mar; 114(3):1126-31. PubMed ID: 122990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hapten-specific T lymphocyte activation by glutaraldehyde-treated macrophages: an argument against antigen processing by macrophages.
    Thomas DW
    J Immunol; 1978 Nov; 121(5):1760-6. PubMed ID: 152327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on the improved effect of anti-TCR alpha beta monoclonal antibody on the induction of transplantation tolerance to the allogeneic skin graft in mice and its mechanisms].
    Hao J; Liu J; Xie S
    Zhonghua Yi Xue Za Zhi; 2001 May; 81(10):593-6. PubMed ID: 11798930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of resistance to L1210 leukemia in BALB/c X DBA/2Cr F1 mice, with L1210 cells treated with glutaraldehyde and concanavalin A.
    Kataoka T; Oh-hashi F; Tsukagoshi S; Sakurai Y
    Cancer Res; 1977 Apr; 37(4):964-8. PubMed ID: 403001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide-induced tolerance in fully allogeneic heart transplantation in mice.
    Matsuura A; Katsuno M; Suzuki Y; Ito T; Yasuura K; Abe T; Yoshikai Y
    Cell Immunol; 1994 May; 155(2):501-7. PubMed ID: 8181080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular composition of spleen and peritoneal exudate in mice after injection of cyclophosphamide-treated L 1210 leukemia cells.
    Skórski T; Kawalec M; Kawiak J
    Folia Histochem Cytobiol; 1987; 25(1):23-7. PubMed ID: 3305097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of antitumor immunity in cyclophosphamide-induced rejection of subcutaneous nonpalpable MOPC-315 tumors.
    Mokyr MB; Hengst JC; Dray S
    Cancer Res; 1982 Mar; 42(3):974-9. PubMed ID: 6977410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.